Genetic risk for mental health disorders is associated with brain structure and the occurrence of psychosis-like experiences in children between 9 and 10 years of age.
A new AI algorithm can successfully predict which children with microdeletion of chromosome 22 will develop schizophrenia and other mental health disorders later in life.
Schizophrenia itself is associated with loss of excitation, but hallucinations and other symptoms of the disorder are caused by a loss of synaptic inhibition.
Toxoplasma exposure can increase the likelihood of developing psychosis in those with risk factors for mental health disorders, a new study reports.
Subtle differences in perception during teenage years predict the development of hallucinations, delusions, and psychosis later in life.
Study reveals an abundance of the CRMP2 protein in people with schizophrenia. The findings could lead to a blood-based biomarker test for the mental health disorder.
A new model of schizophrenia opens the door to a better understanding of, and therapeutic options for brain dysfunction that is at the root of psychosis.
A new theory proposes an imbalance of blood proteins involved in the immune system and in blood clotting networks leads to inflammation that contributes to the development of psychosis.
Prescribing SSRIs during late childhood to those with genetic risk factors for psychosis can reduce the deterioration of intellectual abilities, a new study reveals. SSRIs appear to have a neuroprotective effect for certain brain areas associated with the onset of psychosis if provided early.
Adolescents with higher levels of Omega 3 fatty acids in their blood had a decreased risk of developing psychosis as they entered into early adulthood. At the age of 24, those with psychosis had lower levels of DHA than those without the disorder.
Brain scans revealed, compared to women with low risk for postpartum psychosis, new mothers in high-risk groups had altered brain connectivity in networks associated with goal-orientated behaviors.
A link has been identified between psychosis and a genetic change that alters the immune system in the brain. Researchers found people with psychosis associated with bipolar disorder had decreased expression of GRK3. This led to an increased amount of kynurenic acid in the brain.
